Mr Vaello brings more than 15 years of sales expertise in the oncology and imaging industries to TomoTherapy, where he will be responsible for enhancing sales performance and expanding the company’s global market presence.
Prior to joining TomoTherapy, Mr Vaello served as vice president of sales and field marketing at Philips Healthcare’s oncology imaging division, where he exceeded aggressive budget plans in orders, sales and margin attainment.
Shawn Guse, who held the role of interim vice president of global sales since August 25, 2008, will take on other executive responsibilities within the organization, including continuing as the CEO of TomoTherapy’s proton therapy development subsidiary, Compact Particle Acceleration.
Fred Robertson, CEO of TomoTherapy, said: “Ralph is an experienced, results-oriented sales leader. He has demonstrated repeated success at developing world-class sales organizations that meet or exceed their performance goals. We are confident that Ralph’s deep industry experience and strong management style, combined with our technology’s recognized edge in the treatment of cancer patients, will accelerate our market penetration.”